Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127887381 | 12788738 | 1 | I | 20131117 | 20160928 | 20160928 | PER | US-ASTRAZENECA-2013SE87613 | ASTRAZENECA | 58.00 | YR | M | Y | 99.80000 | KG | 20160928 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127887381 | 12788738 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | U | U | C116044A | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | ||||
| 127887381 | 12788738 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | U | U | 21773 | 2.4 | ML | SOLUTION FOR INJECTION IN PRE-FILLED PEN | Q12H | |||||
| 127887381 | 12788738 | 3 | C | LINSINOPRIL | LISINOPRIL | 1 | 0 | ||||||||||||
| 127887381 | 12788738 | 4 | C | WARFARIN | WARFARIN | 1 | 0 | ||||||||||||
| 127887381 | 12788738 | 5 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 | ||||||||||||
| 127887381 | 12788738 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 127887381 | 12788738 | 7 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127887381 | 12788738 | 8 | C | OMEGA 3 FISH OIL | FISH OILOMEGA-3 FATTY ACIDS | 1 | 0 | ||||||||||||
| 127887381 | 12788738 | 9 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 127887381 | 12788738 | 10 | C | MULTIVITAMIN | VITAMINS | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127887381 | 12788738 | 1 | Type 2 diabetes mellitus |
| 127887381 | 12788738 | 2 | Type 2 diabetes mellitus |
| 127887381 | 12788738 | 3 | Blood pressure abnormal |
| 127887381 | 12788738 | 4 | Anticoagulant therapy |
| 127887381 | 12788738 | 5 | Blood cholesterol abnormal |
| 127887381 | 12788738 | 6 | Fluid retention |
| 127887381 | 12788738 | 7 | Diabetes mellitus |
| 127887381 | 12788738 | 8 | Cardiac disorder |
| 127887381 | 12788738 | 9 | Routine health maintenance |
| 127887381 | 12788738 | 10 | Routine health maintenance |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127887381 | 12788738 | Circumstance or information capable of leading to medication error | |
| 127887381 | 12788738 | Injection site haemorrhage | |
| 127887381 | 12788738 | Injection site pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |